CLINICAL_TRIALS
trial_result
· 2023-12-14
Clinical Trial Update: The Safety and Efficacy of an NAD+ Boosting Product Together With a Low Carbohydrate Diet in Adults With Mild Hypertension and Eligible for Normal-standard-of-care [Phase 2]
Summary
Phase 2 trial evaluating safety and efficacy of an NAD+ boosting product combined with a low-carbohydrate diet in adults with mild hypertension; study completed…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Limitless Research Inc. | Conditions: Hypertension | Phase 2 | Status: COMPLETED